2004
DOI: 10.1016/j.ahj.2003.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Non-st–elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
34
0
3

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(39 citation statements)
references
References 22 publications
2
34
0
3
Order By: Relevance
“…Registry studies also show the superiority of invasive treatments over conservative treatment in elderly NSTE-ACS patients [22,23]. In a 2002 Italian registry, the patients ≥ 75 years of age received treatment consistent with the guidelines less frequently; in the multifactorial analysis, conservative treatment significantly worsened the 30-days prognosis [22]. The analysis of the GRACE (The Global Registry of Acute Coronary Syndromes) registry clearly shows that the patients ≥ 80 years of age, who made up 16% of the population, received treatment consistent with the guidelines less frequently.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Registry studies also show the superiority of invasive treatments over conservative treatment in elderly NSTE-ACS patients [22,23]. In a 2002 Italian registry, the patients ≥ 75 years of age received treatment consistent with the guidelines less frequently; in the multifactorial analysis, conservative treatment significantly worsened the 30-days prognosis [22]. The analysis of the GRACE (The Global Registry of Acute Coronary Syndromes) registry clearly shows that the patients ≥ 80 years of age, who made up 16% of the population, received treatment consistent with the guidelines less frequently.…”
Section: Discussionmentioning
confidence: 99%
“…To sum up randomized trials, it seems that the subgroup analyses, despite their limitations, demonstrate the benefits of invasive treatment in elderly patients with NSTE-ACS, which is consistent with the results of our analysis. Registry studies also show the superiority of invasive treatments over conservative treatment in elderly NSTE-ACS patients [22,23]. In a 2002 Italian registry, the patients ≥ 75 years of age received treatment consistent with the guidelines less frequently; in the multifactorial analysis, conservative treatment significantly worsened the 30-days prognosis [22].…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, troponin-positive patients often did not receive beneficial strategies promptly in The Registry of Acute Coronary Syndromes (TRACS) study [12], and received arteriography less frequently than a conservative strategy in another study (59% vs. 71%; p<0.01) [13].…”
Section: The Need For Risk-assessment Toolsmentioning
confidence: 99%
“…These could include the type of hospital or resources available within the hospital [13]. For example, a study of 1,581 patients enrolled in the Registro Osservazionale Angina Instabile-2 (ROSAI-2) registry in Italy showed that an aggressive strategy of coronary arteriography within 4 days of admission followed by revascularization where feasible was adopted more frequently in patients admitted to hospitals with catheterization facilities, compared with patients admitted to hospitals without such facilities (50% vs. 25%; p<0.001) [13].…”
Section: The Need For Risk-assessment Toolsmentioning
confidence: 99%
“…Coronary artery disease remains the leading cause of morbidity and mortality in this population representing a high burden to the healthcare system [2]. With the improving safety and outcomes of percutaneous coronary intervention (PCI), this is an attractive revascularisation option in very elderly patients for both acute and stable coronary syndromes [3]. PCI in this group of patients is adversely influenced by the presence of multiple comorbidities, reduced physiological adaptation to stress and complex diseased coronary anatomy, thus, the outcomes in these patients, both peri-procedural and longer-term, are less predictable than in younger patients and are they are often excluded from clinical trials [4][5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%